National Science Foundation, Engineering (ENG)
People:
2015 – 2018 Continue Reading Optimal Design of Biomarker-Based Screening Strategies for Early Detection of Chronic Diseases
National Science Foundation, Engineering (ENG)
People:
2015 – 2019 Continue Reading Optimization of Individualized Medical Treatment for Improved Population Health
National Science Foundation, Engineering (ENG)
People:
2012 – 2014 Continue Reading CAREER: Optimization of Screening and Treatment Delivery Systems for Chronic Diseases
Crivelli JJ, Oerline MK, Maalouf NM, Hsi RS, Krampe NA, Smith KB, Best SL, Denton BT, Shahinian VB, Hollingsworth JM. (2026). Adherence to Potassium Citrate, Changes in 24-hour Stone Risk Parameters, and Recurrent Kidney Stone Events. Kidney360
Smith KB, Shen S, Denton BT. (2025). Can past variants of SARS-CoV-2 predict the impact of future variants? Machine learning for early warning of US counties at risk. Health care management science
Agochukwu-Mmonu N, Murali A, Wittmann D, Denton B, Dunn RL, Montie J, Peabody J, Miller D, Singh K, . (2022). Development and Validation of Dynamic Multivariate Prediction Models of Sexual Function Recovery in Patients with Prostate Cancer Undergoing Radical Prostatectomy: Results from the MUSIC Statewide Collaborative. European urology open science, (40)
Ötleş E, Seymour J, Wang H, Denton BT. (2022). Dynamic prediction of work status for workers with occupational injuries: assessing the value of longitudinal observations. Journal of the American Medical Informatics Association : JAMIA
Otero-Leon DF, Lavieri MS, Denton BT, Sussman J, Hayward RA. (2022). Monitoring policy in the context of preventive treatment of cardiovascular disease. Health care management science
Olivier J, Li W, Nieboer D, Helleman J, Roobol M, Gnanapragasam V, Frydenberg M, Sugimoto M, Carroll P, Morgan TM, Valdagni R, Rubio-Briones J, Robert G, Stricker P, Hayen A, Schoots I, Haider M, Moore CM, Denton B, Villers A, . (2021). Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. European urology open science, (35)
Ötleş E, Denton B, Qu B, Murali A, Merdan S, Auffenberg G, Hiller S, Lane BR, George AK, Singh K. (2021). Development and Validation of Models to Predict Pathologic Outcomes of Radical Prostatectomy in Regional and National Cohorts. The Journal of urology
Zhang Z, Modi PK, Shahinian V, Herrel LA, Dupree JM, Yan P, Denton BT. (2020). Active Surveillance vs Immediate Treatment-Which Has a Greater Financial Incentive for Urologists?. Urology practice, 7(3)
Inadomi M, Singh K, Qi J, Dunn R, Linsell S, Denton B, Hurley P, Kleer E, Montie J, Ghani KR, . (2020). Prospective monitoring of imaging guideline adherence by physicians in a surgical collaborative: comparison of statistical process control methods for detecting outlying performance. BMC medical informatics and decision making, 20(1)
Li W, Denton BT, Nieboer D, Carroll PR, Roobol MJ, Morgan TM, . (2020). Comparison of biopsy under-sampling and annual progression using hidden markov models to learn from prostate cancer active surveillance studies. Cancer medicine, 9(24)
Barnett CL, Davenport MS, Montgomery JS, Kunju LP, Denton BT, Piert M. (2019). F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 2. Cost-Effectiveness Analysis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 60(12)
Shankar PR, Maturen KE, George AK, Borza T, Ellimoottil C, Montgomery JS, Wei JT, Denton BT, Davenport MS. (2019). Temporary Health Impact of Prostate MRI and Transrectal Prostate Biopsy in Active Surveillance Prostate Cancer Patients. Journal of the American College of Radiology : JACR, 16(10)
VonAchen P, Hayward RA, Norton EC, Denton B, Ellimoottil C. (2018). The Challenge of Measuring Surgeon Spending for Payment Policies. Annals of surgery, 268(6)
Denton BT, Hawley ST, Morgan TM. (2019). Optimizing Prostate Cancer Surveillance: Using Data-driven Models for Informed Decision-making. European urology, 75(6)
Auffenberg GB, Ghani KR, Ramani S, Usoro E, Denton B, Rogers C, Stockton B, Miller DC, Singh K, . (2019). askMUSIC: Leveraging a Clinical Registry to Develop a New Machine Learning Model to Inform Patients of Prostate Cancer Treatments Chosen by Similar Men. European urology, 75(6)
Kirmiz S, Qi J, Babitz SK, Linsell S, Denton B, Singh K, Auffenberg G, Montie JE, Lane BR. (2019). Grade Groups Provide Improved Predictions of Pathological and Early Oncologic Outcomes Compared with Gleason Score Risk Groups. The Journal of urology, 201(2)
Barnett CL, Davenport MS, Montgomery JS, Wei JT, Montie JE, Denton BT. (2018). Cost-effectiveness of magnetic resonance imaging and targeted fusion biopsy for early detection of prostate cancer. BJU international, 122(1)
Basu S, Sussman JB, Rigdon J, Steimle L, Denton BT, Hayward RA. (2017). Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials. PLoS medicine, 14(10)
Zhang Y, Wu H, Denton BT, Wilson JR, Lobo JM. (2019). Probabilistic sensitivity analysis on Markov models with uncertain transition probabilities: an application in evaluating treatment decisions for type 2 diabetes. Health care management science, 22(1)
Auffenberg GB, Merdan S, Miller DC, Singh K, Stockton BR, Ghani KR, Denton BT. (2017). Evaluation of Prostate Cancer Risk Calculators for Shared Decision Making Across Diverse Urology Practices in Michigan. Urology, (104)
Capan M, Khojandi A, Denton BT, Williams KD, Ayer T, Chhatwal J, Kurt M, Lobo JM, Roberts MS, Zaric G, Zhang S, Schwartz JS. (2017). From Data to Improved Decisions: Operations Research in Healthcare Delivery. Medical decision making : an international journal of the Society for Medical Decision Making, 37(8)
Barnett CL, Auffenberg GB, Cheng Z, Yang F, Wang J, Wei JT, Miller DC, Montie JE, Mamawala M, Denton BT. (2018). Optimizing active surveillance strategies to balance the competing goals of early detection of grade progression and minimizing harm from biopsies. Cancer, 124(4)
Gopalakrishna A, Fantony JJ, Longo TA, Owusu R, Foo WC, Dash R, Denton BT, Inman BA. (2017). Anticipatory Positive Urine Tests for Bladder Cancer. Annals of surgical oncology, 24(6)
Barnett CL, Tomlins SA, Underwood DJ, Wei JT, Morgan TM, Montie JE, Denton BT. (2017). Two-Stage Biomarker Protocols for Improving the Precision of Early Detection of Prostate Cancer. Medical decision making : an international journal of the Society for Medical Decision Making, 37(7)
Merdan S, Tomlins SA, Barnett CL, Morgan TM, Montie JE, Wei JT, Denton BT. (2015). Assessment of long-term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy. Cancer, 121(22)
Liu J, Womble PR, Merdan S, Miller DC, Montie JE, Denton BT, . (2015). Factors Influencing Selection of Active Surveillance for Localized Prostate Cancer. Urology, 86(5)
Zhang Y, McCoy RG, Mason JE, Smith SA, Shah ND, Denton BT. (2014). Response to comments on Zhang et al. Second-line agents for glycemic control for type 2 diabetes: are newer agents better? Diabetes Care 2014;37:1338-1345. Diabetes care, 37(9)
Risko R, Merdan S, Womble PR, Barnett C, Ye Z, Linsell SM, Montie JE, Miller DC, Denton BT. (2014). Clinical predictors and recommendations for staging computed tomography scan among men with prostate cancer. Urology, 84(6)
If you’d like to update your profile, please email modifications to questions@midasnetwork.us.